Arbutus Biopharma (ABUS) Return on Invested Capital (2016 - 2022)

Arbutus Biopharma has disclosed Return on Invested Capital across 6 years of filings, most recently posting 0.0% for Q4 2022.

• Return on Invested Capital for Q4 2022 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was 0.0% (changed N/A YoY), and the FY2022 annual result was 0.0%, changed N/A from the prior year.
• Return on Invested Capital came in at 0.0% for Q4 2022 at Arbutus Biopharma, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2018 to a low of 0.02% in Q1 2020.
• The 4-year median for Return on Invested Capital is 0.0% (2019), against an average of 0.01%.
• Across the five-year window, Return on Invested Capital grew 1 bps in 2018 and fell 1 bps in 2019, its largest moves.
• Arbutus Biopharma's Return on Invested Capital stood at 0.0% in 2018, then sank by 634 bps to 0.02% in 2019, then dropped by 1 bps to 0.02% in 2020, then jumped by 71 bps to 0.0% in 2022.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2022), 0.0% (Q3 2022), and 0.0% (Q2 2022), per Business Quant data.